Genflow Biosciences plc (LON:GENF – Get Free Report)’s share price rose 5% on Thursday . The stock traded as high as GBX 2.10 and last traded at GBX 2.10. Approximately 989,842 shares were traded during trading, a decline of 52% from the average daily volume of 2,064,951 shares. The stock had previously closed at GBX 2.
Genflow Biosciences Stock Up 5.0%
The firm has a market capitalization of £11.89 million, a PE ratio of -6.33 and a beta of 2.27. The business has a 50-day moving average price of GBX 1.99 and a 200-day moving average price of GBX 2.06.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
